MASS MAIL 07 SEPTEMBER 2005 - TRIPLE BOTTOM LINE

FOUNDATION FOR THE DEVELOPMENT OF AFRICA
"Participation Builds Unity"

"MADE IN AFRICA - FOR AFRICA"

FDA NEWSLETTER

MASS MAIL
07 SEPTEMBER 2005
TRIPLE BOTTOM LINE
(All)

**********************************

The FOUNDATION FOR THE DEVELOPMENT OF AFRICA proudly presents you with the following information that may add value to Africa's development. Please direct any correspondence to: info@isupportafrica.com

THE FDA - YOUR CSI/R (TRIPLE BOTTOM LINE) PARTNER
FOR THE RECORD

THE FDA - YOUR CSI/R PARTNER
Within the framework of the Triple Bottom Line (Economics; Environment and Social), emerging internationally, the FOUNDATION FOR THE DEVELOPMENT OF AFRICA (FDA) has now opted to assist business by partnering with select corporates/SME/organisations that lack or have failed to recognise or capitalize on their Corporate Social Investment Programme.

As a 'not-for-profit' organisation the FOUNDATION FOR THE DEVELOPMENT OF AFRICA (FDA) is very well positioned to partner with business and represent these CSI (Corporate Social Investment) or CSR (Corporate Social Responsibility) efforts in a coordinated programme.

Please make contact should you wish to discuss this interesting FDA initiative:
peter@isupportafrica.com

FOR THE RECORD
The FOUNDATION FOR THE DEVELOPMENT OF AFRICA (FDA) is a private 'not-for-profit' organisation actively involved with initiating and facilitating business and other processes conducive to sustainable development in Africa - with the emphasis on sustainability! The FDA is currently rated as one of the most proactive Business Development Organizations in Africa - serving Africa since 1999.

We are also actively involved with promoting the AFRICAN RENEWAL PROGRAMME alongside the NEPAD initiative. We firmly believe that sustainable development is a process that must start from within - Africa needs to 'partner' with herself first! - We promote the phrase: "Lets create wealth" rather than "Lets alleviate poverty"

Our website(s) has achieved remarkable recognition from www.google.com; www.yahoo.com and www.msn.com due to clever site optimization and reliable value-add content with regard Africa's development.

For three years we focused the optimization of our websites on two basic 'search' phrases: "business development africa" and "support africa". I deemed these two 'questions' to be the most 'frequently asked' by the international community and then most 'complimentary' to the content of our websites!

I have no doubt that the selection of these 'optimized phrases' to be part of our successful branding. A www.yahoo.com search, for "support africa", delivers around 102,000,000 (102 million) WebPages. To be listed three times within the top-ten, on this search, is phenomenal.

Currently the FDA website(s) provide a host of 'services' all highly ranked by the leading search portals in the world. We have identified some 74 'phrases' - popular 'phrases' enjoying preferred rankings include:
* business opportunities africa
http://www.foundation-development-africa.org/africa_business_opportunities/index.htm
* investment opportunities africa
http://www.foundation-development-africa.org/africa_investment_opportunities/index.htm
* black business development africa
http://www.foundation-development-africa.org/africa_black_business/index.htm
* special projects africa
http://www.foundation-development-africa.org/africa_special_projects/index.htm
* upcoming events africa
http://www.foundation-development-africa.org/africa_upcoming_events/index.htm
* corporate social investment africa
http://www.foundation-development-africa.org/africa_corporate_social_investment/index.htm

We remain proud of this achievement and would like to thank HITECH MARKETING for their support in achieving this:
http://www.fdapartners.net/partners/hitech_marketing.htm
or
http://www.hitechmarketing.co.za

For Africa to succeed in her efforts to develop and prosper ALL of Africa need to take hands.

Take care

COMMENTS RECEIVED

***********************************

BACK TO
FDA NEWLETTER
INDEX PAGE COMMENT?
SEND US AN
EMAIL BACK TO
FDA MAIN INDEX
FRONT PAGE

**********************************